...
首页> 外文期刊>Journal of periodontal research >Tumor necrosis factor- antagonist infliximab inhibits osteoclast formation of peripheral blood mononuclear cells but does not affect periodontal ligament fibroblast-mediated osteoclast formation
【24h】

Tumor necrosis factor- antagonist infliximab inhibits osteoclast formation of peripheral blood mononuclear cells but does not affect periodontal ligament fibroblast-mediated osteoclast formation

机译:肿瘤坏死因子拮抗剂英夫利昔单抗抑制外周血单核细胞的破骨细胞形成,但不影响牙周膜成纤维细胞介导的破骨细胞形成

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Background and ObjectiveThe inflammatory cytokine tumor necrosis factor-alpha (TNF-) is elevated in inflamed periodontal tissues and may contribute to periodontitis progression. TNF- stimulates formation and activity of osteoclasts, the cells that are recruited in periodontitis, that cause alveolar bone degradation and subsequent tooth loss. We previously showed that TNF- is elevated in co-cultures of periodontal ligament fibroblast (PDLF) and peripheral blood mononuclear cells (PBMC). Hence, TNF- could be a determining factor in osteoclast formation in these cultures, as osteoclasts are formed despite the fact that prototypical osteoclast differentiation factor receptor activator of nuclear factor kappa-B ligand is outnumbered at least 100-fold by its inhibitor osteoprotegerin in these cultures.
机译:背景与目的炎性细胞因子肿瘤坏死因子-α(TNF-)在发炎的牙周组织中升高,可能有助于牙周炎的进展。 TNF-α刺激破骨细胞的形成和活性,破骨细胞是在牙周炎中募集的细胞,引起牙槽骨降解和随后的牙齿脱落。我们先前显示,在牙周膜成纤维细胞(PDLF)和外周血单核细胞(PBMC)的共培养物中,TNF-α水平升高。因此,TNF-α可能是这些培养物中破骨细胞形成的决定性因素,尽管尽管在这些培养基中其核因子κB配体的原型破骨细胞分化因子受体激活剂的数量至少是其破骨细胞保护蛋白的至少100倍,但仍形成了破骨细胞文化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号